News | February 25, 2015

Seattle Cancer Care Alliance Proton Therapy Adds New Advanced Treatment Options

Pencil beam scanning, breath-hold device among new innovations

SCCA, proton therapy, radiation, RaySearch, RayStation, Active Breathing

February 25, 2015 — Physicians treating patients with complex tumors will have more advanced treatment options at Seattle Cancer Care Alliance Proton Therapy, a ProCure Center. The center will now offer pencil beam scanning (PBS) in its state-of-the-art gantry room. The combination of proton therapy with PBS technology enables physicians to better shape and direct radiation to the tumor, opening the doors to treat a wider variety of cancers.

“PBS is the most advanced way to deliver proton radiation and will allow us to sculpt protons for treating more complex tumors, such as in the head and neck, lung, abdomen, and pelvic areas,” said Smith ‘Jim’ Apisarnthanarax, M.D., a radiation oncologist at SCCA Proton Therapy.

SCCA Proton Therapy has also recently become the first proton center to use an advanced breath-hold device that aids patients in their ability to control breathing during radiation treatment. The Active Breathing Coordinator (ABC) device may be used when treating tumors in the chest or abdomen that move with breathing. It assists patients with systematically holding their breath before or after they’ve breathed out.

During this brief time, the ABC device makes the tumor a stationary target, allowing the treatment to be even more accurate, sparing surrounding tissue. The device’s ability to control breath both on inhale and exhale allows physicians to treat a range of tumors.

In addition, University of Washington Medicine physicians and SCCA Proton Therapy physicists are working together to upgrade the process for developing PBS patient treatment plans with RaySearch Laboratories‘ advanced treatment-planning and dose-tracking software platform, RayStation. RayStation combines the capabilities of traditional imaging such as computed tomography (CT), positron emission tomography (PET) and magnetic resonance imaging (MRI), with contouring and 4-D compatibility. Other features include multi-criteria optimization, dose tracking, treatment adaptation and near-real-time deformable image registration.

“Providing patients with the best treatment possible is our No. 1 priority and we believe investing in these advancements allows us to provide them with the highest levels of care,” said Ramesh Rengan, M.D., medical director at SCCA Proton Therapy. “These innovative technologies will make treatments more effective for patients, while shortening the overall treatment course for select cancers.”

For more information: www.sccaprotontherapy.com

Related Content

Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
RaySearch Launches RayCare Oncology Information System

Image courtesy of RaySearch Laboratories

Technology | Oncology Information Management Systems (OIMS) | December 22, 2017
RaySearch announced the first release of RayCare, a new oncology information system (OIS) designed to connect the...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Overlay Init